세계의 말초 정맥 카테터 시장(2023-2030년)

Overview

Global Peripheral IV Catheters Market reached US$ 5.2 billion in 2022 and is expected to reach US$ 9.1 billion by 2030, growing with a CAGR of 7.4% during the forecast period 2023-2030.

Peripheral intravenous catheters (PIVCs) are the most commonly used intravenous devices which are primarily used for therapeutic purposes such as the administration of medications, fluids, and blood products. The catheter location, patency/occlusion, limb symmetry, any evidence of phlebitis (erythema, discomfort, swelling, pain, etc.), pressure injuries, and signs of infiltration/extravasation injuries are all evaluated in the assessment of peripheral IV Catheters.

Furthermore, the global peripheral IV catheter market is driven by a rise in the prevalence of chronic disorders, technological advancements, a rise in minimally invasive procedures, and strong healthcare expenditures that will drive the market during the forecast period.

Dynamics

Rise in the Prevalence of Cardiovascular Diseases

Patients with certain cardiovascular conditions, such as atrial fibrillation or deep vein thrombosis, may require anticoagulation treatment to avoid blood clots. Intravenous (IV) catheters can supply anticoagulant drugs like heparin to maintain healthy blood flow. The rise in the incidence of cardiovascular diseases is the significant key driver that drives the market during the forecast period.

For instance, according to the Centres for Disease Control and Prevention's updated factsheet 2023, heart disease is the main cause of death in the United States for men, women, and individuals of most racial and ethnic groups. In the United States, one person dies from cardiovascular disease every 33 seconds.

Approximately 695,000 persons in the United States died from heart disease in 2021, accounting for one out of every five fatalities. From 2018 to 2019, the United States spent around $239.9 billion on heart disease. This covers the expense of healthcare services, medications, and lost productivity as a result of mortality.

Rise in the Technological Advancements

Rise in the technological advancements is one of the key factors that drive the market during the forecast period. For instance, in April 2023, BD, a global medical technology company, launched the BD Prevue II System, an advanced ultrasound device with a specialized probe for optimal IV placement.

The system addresses the unmet need for IV access through real-time needle depth markers and features the BD Cue Needle Tracking System, providing high-quality ultrasound images of the needle trajectory. It is compatible with BD Cue Needle Tracking-enabled catheters. The BD Prevue II System is designed to provide clinicians with optimal IV placement and is easy to use.

Rise in the Geriatric Population

As the population ages, more medical procedures, such as intravenous therapy, are required. The need for peripheral IV catheters to provide medicine and fluids develops in tandem with the ageing population.

The elderly are more vulnerable to heart problems. The increased prevalence of age-related cardiac problems is predicted to increase demand for pacemakers as the global geriatric population grows.

For instance according to an article published by Clinical Cardiology Around 60% of the US population over the age of 60 have hypertension, leading to heart attacks which result in increased demand for peripheral iv catheters requirement. By 2060, the number of people aged 65 and over will reach 25% of the US population, with 20 Billion beyond the eighth decade.

Rising Needle-Stick Injuries Encouraging The Adoption of Peripheral Intravenous Catheters

For patients who require frequent injections, needle stick injuries from injection needles are a major problem. Handling, disassembling, or even disposal of needles and syringes can result in percutaneous wound injuries from needle tips. According to the America Medical Association Needle sticks are a common occurrence in the healthcare profession. It is estimated that 600 000 to 800 000 needlestick injuries occur per year in the United States.

For instance, In July 2022, B. Braun Medical Inc, a leader in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and exposure to blood

Risks and Complications Associated with the Catheters

Complications of PIVC in situ can arise, although they can be avoided with adequate aseptic procedures and device evaluation. Infection, phlebitis, catheter/fluid/medication presence, and difficulties with chronically unwell patients are all common consequences. When fluids or drugs are transported into surrounding tissue, infiltration/extravasation occurs; if this occurs, see the extravasation injury management nursing guideline. These issues can be avoided by employing proper aseptic techniques and evaluation.

Segment Analysis

The Global Peripheral IV Catheters market is segmented based on product, technology, end user and region.

The Integrated Peripheral Intravenous Catheters From The Product Segment Accounted for Approximately 42.5% of the Peripheral IV Catheters Share

The integrated peripheral intravenous catheters from the product segment with around 42.5% is expected to dominate during the forecast period. People adjusting the catheter to attach the extension set cause internal pressures in the vein to be reduced with integrated peripheral intravenous catheters. Following insertion, the use of integrated catheters offers additional fluid tubing connections or direct injections conducted via the dedicated port, which is somewhat upstream of the catheter itself and limits the movement of the catheter body against the internal vein wall.

For instance, according to research published in the British Journal of Nursing in August 2022, a close/integrated catheter reduces the danger of the healthcare professional coming into touch with the patient's blood and enables the safe collection of blood samples. It can assist prevent backflow into the cannula tip, minimising the risk of obstruction and the need for several insertions. It is also critical that the device stays stable after insertion to minimise micro-movements within the vessel (which might damage the tunica intima, resulting in mechanical phlebitis.

Geographical Penetration

North America Accounted for Approximately 39.6% of the Market Share

North America is estimated to hold about 39.6% of the total market share throughout the forecast period due to launches by the key players, rising chronic diseases and a growing senior population. Also, North America has sophisticated healthcare facilities, and the reimbursement coverage contributes to the large market share of the region

For instance, in March 2022, Shockwave Medical, Inc, a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced the global commercial availability of the Shockwave M5 + peripheral IVL catheter after receiving both CE Mark and U.S. Food and Drug Administration (FDA) clearance. The Shockwave M5 + catheter, which has been in limited launch until today, is specifically designed to decrease IVL treatment time, provide alternative access options, and expand IVL therapy to patients with larger vessel sizes.

Competitive Landscape

The major global players in the market include: Becton Dickinson, B. Braun Melsungen AG, Argon Medical, Vygon, ICU Medical Inc, VOGT Medical, RenovoRx Inc, Nipro Medical, Teleflex, Greiner Bio-One and among others.

COVID-19 Impact Analysis

Covid has a huge influence on the peripheral intravenous catheter market, which is facing substantial challenges The main issue is the difficulty to access raw materials required for the fabrication of peripheral intravenous catheters due to transportation facility issues. Furthermore, due to an increase in the number of patients suffering from COVID-19 and other life-threatening illnesses, product distributors are seeing unpredictable demand from retailers.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict had a moderate impact on the global peripheral IV catheters market, owing to the disruption of supply chains and the shortage of healthcare infrastructure where the impact directly hit on these factors. Overall, the impact of the import and export of devices is expected to have an influence on the overall global peripheral IV catheters market growth over the forecast period.

By Product

• Integrated/Closed Peripheral Intravenous Catheters
• Short Peripheral Intravenous Catheters
  • Ported PIVC
  • Non-Ported PIVC

• Midline Catheters

By Technology

• Conventional PIVC
• Systems PIVC

By End User

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• In September 2022 B. B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced it has acquired the innovative Clik-FIX catheter securement device portfolio from Starboard Medical, Inc. B. Braun's acquisition builds on the company's history of product and program innovation to improve the patient experience and outcomes with peripheral intravenous (IV) therapy.
• In May 2022, Access Vascular, Inc. (AVI) announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HydroPICC Dual-Lumen catheter. Designed and constructed using the same proprietary hydrophilic biomaterial as AVI's single-lumen HydroPICC and HydroMID catheters, these devices showed a significant reduction in complications such as occlusions, replacements, Deep Vein Thrombosis and phlebitis in recent studies.

Why Purchase the Report?

• To visualize the global Peripheral IV Catheters market segmentation based on product, technology, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of Peripheral IV Catheters market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global Peripheral IV Catheters market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Technology
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the Prevalence of Cardiovascular Diseases
    • 4.1.1.2. Rise in the Technological Advancements
    • 4.1.1.3. Rise in the Geriatric Population
    • 4.1.1.4. Rising Needle-Stick Injuries Encouraging the Adoption of Peripheral Intravenous Catheters
  • 4.1.2. Restraints
    • 4.1.2.1. Risks and Complications Associated with the Catheters
  • 4.1.3. Opportunity
    • 4.1.3.1. Rise in the Minimal Invasive Procedures
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Integrated/Closed Peripheral Intravenous Catheters *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Short Peripheral Intravenous Catheters
• 7.4. Midline Catheters

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 8.1.2. Market Attractiveness Index, By Technology
• 8.2. Conventional PIVC*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Systems PIVC

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers
• 9.4. Clinics

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Application
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. UK
    • 10.3.7.3. France
    • 10.3.7.4. Italy
    • 10.3.7.5. Spain
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Becton Dickinson*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. B. Braun Melsungen AG
• 12.3. Argon Medical
• 12.4. Vygon
• 12.5. ICU Medical, Inc
• 12.6. VOGT Medical
• 12.7. RenovoRx Inc
• 12.8. Nipro Medical
• 12.9. Teleflex
• 12.10. Griener Bio One

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us